Chris Freeman is Chief Commercial Officer of Guardant Health, Inc.. Currently has a direct ownership of 42,292 shares of GH, which is worth approximately $1.9 Million. The most recent transaction as insider was on Jun 15, 2023, when has been sold 4,879 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 42.3K
21.99% 3M change
164.8% 12M change
Total Value Held $1.9 Million

Chris Freeman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 15 2023
BUY
Exercise of conversion of derivative security
-
4,879 Added 35.05%
9,040 Common Stock
Jun 15 2022
SELL
Payment of exercise price or tax liability
$64,853 $38.42 p/Share
1,688 Reduced 34.6%
3,191 Common Stock
Jun 15 2022
BUY
Exercise of conversion of derivative security
-
4,879 Added 50.0%
4,879 Common Stock
CF

Chris Freeman

Chief Commercial Officer
Redwood City, CA

Track Institutional and Insider Activities on GH

Follow Guardant Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GH shares.

Notify only if

Insider Trading

Get notified when an Guardant Health, Inc. insider buys or sells GH shares.

Notify only if

News

Receive news related to Guardant Health, Inc.

Track Activities on GH